SCHEMBL506537

SCHEMBL506537

CC(=O)c1ccc(CBr)cc1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.67
▸ LMNA P02545 2/20 0.57
▸ CES2 O00748 1/20 0.57
▸ CES1 P23141 1/20 0.57
▸ HSD17B10 Q99714 1/20 0.52
▸ MAOB P27338 5/20 0.50
▸ HPGD P15428 2/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ PYCR1 P32322 1/20 0.47
▸ HSD17B1 P14061 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ MAOA P21397 1/20 0.46
▸ GAA P10253 1/20 0.45
▸ EPHX2 P34913 1/20 0.44
▸ NR1H4 Q96RI1 1/20 0.44
▸ HRH3 Q9Y5N1 1/20 0.44
▸ MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL28106863 0.98 KMT2A (0.64) KMT2ALMNACES2CES1HSD17B10
SCHEMBL31395448 0.88 MAPT (0.70) KMT2ALMNACES2CES1MAOB
SCHEMBL253937 0.82 KMT2A (0.61) KMT2ALMNAHSD17B10MAOBHPGD
SCHEMBL12375837 0.82 CES2 (0.64) KMT2ALMNACES2CES1HSD17B10
Acetone SCHEMBL28624234 0.82 ALDH1A1 (0.59) KMT2ACES2CES1L3MBTL1MAPT
Phenacyl Chloride SCHEMBL28106868 0.81 ALDH1A1 (0.59) KMT2ALMNACES2CES1HSD17B10
Benzonitrile SCHEMBL28107146 0.81 CES2 (0.53) KMT2ALMNACES2CES1HSD17B10
SCHEMBL6859304 0.80 KMT2A (1.00) KMT2ALMNAHSD17B10MAOBHPGD
SCHEMBL9818052 0.80 KMT2A (0.73) KMT2ALMNAHSD17B10MAOBHPGD
SCHEMBL35800 0.80 CES2 (0.61) KMT2ACES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118206417-A Cobalt catalytic dehalogenation deuteration method 中国科学院大连化学物理研究所 2024-06-18 — — CN claimed
CN-113620820-B Functionalized magnetic ionic liquid and preparation method and application thereof 辽宁大学 2023-12-29 — — CN claimed
CN-115232073-B Preparation and application of 1H-naphthalene [2,3-d ] imidazole-based light-responsive organic long afterglow material 南京邮电大学 2022-11-22 — — CN claimed
CN-115232073-A Preparation and application of 1H-naphthalene [2,3-d ] imidazole-based light-responsive organic long afterglow material 南京邮电大学 2022-10-25 — — CN claimed
CN-112321535-B Preparation method of immaric acid or hydrochloride thereof 江苏八巨药业有限公司 2022-04-19 — — CN claimed
CN-112321535-A Preparation method of immaric acid or hydrochloride thereof 江苏八巨药业有限公司 2021-02-05 — — CN claimed
CN-110305048-A One kind preparing α-sulfuryl ketone compounds synthetic method by α, α-two bromo ketone one kettle way 温州大学 2019-10-08 — — CN claimed
CN-105148713-A Method for removing sulfur dioxide, sulfur trioxide and hydrogen sulfide in tail gas of oil burning boiler YE CHENG 2015-12-16 — — CN claimed
CN-105148694-A Treating agent for removing sulfur dioxide, sulfur trioxide and hydrogen sulfide from tail gas of oil burning boiler YE CHENG 2015-12-16 — — CN claimed
CN-103755715-B Cumarone is [2,3-c] pyridine compounds and synthetic method thereof also WUHAN UNIVERSITY OF TECHNOLOGY (CN) 2015-12-09 — — CN claimed
CN-103755715-A Benzofuran [2, 3-c] pyridine compound and synthetic method thereof UNIV WUHAN TECH 2014-04-30 — — CN claimed
CN-101336242-A Improved method of preparation for imidazolepyridines MALLINCKRODT INC (US) 2008-12-31 — — CN claimed
EP-4658656-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES Beone Medicines I GmbH (CH) 2025-12-10 — — EP disclosed
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES BEONE MEDICINES I GMBH (CH) 2025-11-13 — — US disclosed
EP-4021901-B1 SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS BRISTOL MYERS SQUIBB CO (US) 2025-09-24 — — EP disclosed
US-20250263402-A1 BENZIMIDAZOLONE GLP-1 RECEPTOR AGONIST AND USE THEREOF HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (CN) 2025-08-21 — — US disclosed
US-4181677-A ANTIINFLAMMATORY AGENTS AMERICAN CYANAMID COMPANY (US) 1980-01-01 — — US disclosed
US-4173650-A ANTIARTHRITIC AGENTS AMERICAN CYANAMID COMPANY (US) 1979-11-06 — — US disclosed
US-4118561-A ANTIBACTERIAL, SYNERGISTIC, ANTI-CANCER ACTIVITY, ANTI-FOLIC ACID ACTIVITY AMERICAN HOME PRODUCTS CORPORATION (US) 1978-10-03 — — US disclosed
US-3931268-A Methylhydrazinomethyl-substituted benzoic acid amides HOFFMANN-LA ROCHE INC. (US) 1976-01-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250263402-A1 BENZIMIDAZOLONE GLP-1 RECEPTOR AGONIST AND USE THEREOF GLP1R, GIPR, GCGR KMT2A 3283/4885LMNA 3704/4885CES2 4427/4885
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES DGKG, DGKA, DGKK KMT2A 2375/4885LMNA 3162/4885CES2 3346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback